BG Medicine Inc (BGMD)
BG Medicine Inc. is a healthcare company focused on developing and commercializing diagnostic tests, with an emphasis on cardiovascular applications. Its products include the BGM Galectin-3 test, which measures galectin-3 in blood plasma or serum, and the CardioSCORE test, designed to help identify cardiovascular events such as heart attack and stroke. The company has operated under its current name since October 2004, when it changed from Beyond Genomics, Inc. Incorporated in 2000, BG Medicine is headquartered in Waltham, Massachusetts. The company’s common stock trades on the OTC Markets under the symbol BGMD.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-BGMD
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
0.011 K
|